BCKDK antibody (N-Term)
Quick Overview for BCKDK antibody (N-Term) (ABIN632248)
Target
See all BCKDK AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- BCKDK antibody was raised against the N terminal of BCKDK
-
Purification
- Affinity purified
-
Immunogen
- BCKDK antibody was raised using the N terminal of BCKDK corresponding to a region with amino acids CLPFIIGCNPTILHVHELYIRAFQKLTDFPPIKDQADEAQYCQLVRQLLD
-
-
-
-
Application Notes
-
WB: 0.5 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
BCKDK Blocking Peptide, (ABIN937128), is also available for use as a blocking control in assays to test for specificity of this BCKDK antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of BCKDK antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- BCKDK (Branched Chain Ketoacid Dehydrogenase Kinase (BCKDK))
-
Alternative Name
- BCKDK
-
Background
- BCkDaK belongs to the PDK/BCkDaK protein kinase family. It contains 1 histidine kinase domain. BCkDaK catalyzes the phosphorylation and inactivation of the branched-chain alpha-ketoacid dehydrogenase complex, the key regulatory enzyme of the valine, leucine and isoleucine catabolic pathways. BCkDaK is the key enzyme that regulates the activity state of the BCkDa complex.
-
Molecular Weight
- 43 kDa (MW of target protein)
-
Pathways
- SARS-CoV-2 Protein Interactome
Target
-